Advances in Clinical Chemistry

<ol> <li>Biomarkers in Breast Cancer: Where Are We and Where Are We Going?</li> <p>Michael J. Duffy, Siun Walsh, Enda W. McDermott and John Crown</p> <p> <li>Polycystic Ovary Syndrome- Epigenetic Mechanisms and Aberrant MicroRNA </li> <p>Ioana R. Ilie and Carmen E. Georgescu</p> <p> <li>EN2 in Prostate Cancer</li> <p>Sophie E. McGrath, Agnieszka Michael, Richard Morgan and Hardev Pandha.</p> <p> <li>Cytochrome P450 in Cancer Susceptibility and Treatment</li> <p>Balraj Mittal, Sonam Tulsyan, Surendra Kumar, Rama Devi Mittal and Gaurav Agarwal</p> <p> <li>The Importance of Accurately Assessing Renal Function in the Neonate and Infant</li> <p>Guido Filler, Laudelino Lopes and Mark Awuku</p> <p> <li>Systematic Assessment of the Hemolysis Index: Pros and Cons</li> <p>Giuseppe Lippi</p> <p> <li>Peroxisome Proliferator-Activated Receptor α in Lipid Metabolism and AtherosclerosisXiao-Hua Yu, Xi-Long Zheng and Chao-Ke Tang</li></ol>